Metabolic control through glucocorticoid hormones: An update

Molecular and Cellular Endocrinology

Volumn 380, Issue 1-2, 2013, Pages 65-78

  Rose, Adam J ^a   Herzig, Stephan ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Glucocorticoid receptor; Insulin resistance; Metabolic disease; Metabolism; Obesity; Type 2 diabetes

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; BILE ACID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INSULIN; TRIACYLGLYCEROL;

ADIPOCYTE; ARTICLE; CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; CUSHING SYNDROME; DIET RESTRICTION; ENERGY METABOLISM; FATTY LIVER; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN METABOLISM; SKELETAL MUSCLE;

GLUCOCORTICOID RECEPTOR; INSULIN RESISTANCE; METABOLIC DISEASE; METABOLISM; OBESITY; TYPE 2 DIABETES;

ADIPOSE TISSUE; ANIMALS; CARBOHYDRATE METABOLISM; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIVER; METABOLIC DISEASES; MUSCLE, SKELETAL; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84884530630     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.03.007     Document Type: Article

References (211)

1. Anbalagan M., Huderson B., Murphy L., Rowan B.G. Post-translational modifications of nuclear receptors and human disease. Nucl. Recept. Signal. 2012, 10:e001.
2. Arnaldi G., Scandali V.M., Trementino L., Cardinaletti M., Appolloni G., Boscaro M. Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology 2010, 92(Suppl. 1):86-90.
3. Asada M., Rauch A., Shimizu H., Maruyama H., Miyaki S., Shibamori M., Kawasome H., Ishiyama H., Tuckermann J., Asahara H. DNA binding-dependent glucocorticoid receptor activity promotes adipogenesis via Kruppel-like factor 15 gene expression. Lab. Invest. 2011, 91:203-215.
4. Baehr L.M., Furlow J.D., Bodine S.C. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol 2011, 589:4759-4776.
5. Baid S.K., Nieman L.K. Therapeutic doses of glucocorticoids: implications for oral medicine. Oral Dis. 2006, 12:436-442.
6. Barthel A., Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 2003, 285. E685-92.
7. Beaufrere B., Horber F.F., Schwenk W.F., Marsh H.M., Matthews D., Gerich J.E., Haymond M.W. Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am. J. Physiol. 1989, 257:E712-E721.
8. Bernal-Mizrachi C., Weng S., Feng C., Finck B.N., Knutsen R.H., Leone T.C., Coleman T., Mecham R.P., Kelly D.P., Semenkovich C.F. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat. Med. 2003, 9:1069-1075.
9. Bernal-Mizrachi C., Xiaozhong L., Yin L., Knutsen R.H., Howard M.J., Arends J.J., Desantis P., Coleman T., Semenkovich C.F. An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab. 2007, 5:91-102.
10. Berneis K., Ninnis R., Girard J., Frey B.M., Keller U. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man. J. Clin. Endocrinol. Metab. 1997, 82:2528-2534.
11. Birkenhager J.C., Timmermans H.A., Lamberts S.W. Depressed plasma FFA turnover rate in Cushing's syndrome. J. Clin. Endocrinol. Metab. 1976, 42:28-32.
12. Bjorntorp P., Rosmond R. Visceral obesity and diabetes. Drugs 1999, 58(Suppl 1):13-18. (discussion 75-82).
13. Blondeau B., Sahly I., Massourides E., Singh-Estivalet A., Valtat B., Dorchene D., Jaisser F., Breant B., Tronche F. Novel transgenic mice for inducible gene overexpression in pancreatic cells define glucocorticoid receptor-mediated regulations of beta cells. PLoS One 2012, 7:e30210.
14. Borgius L.J., Steffensen K.R., Gustafsson J.A., Treuter E. Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP. J. Biol. Chem. 2002, 277:49761-49766.
15. Boustead J.N., Stadelmaier B.T., Eeds A.M., Wiebe P.O., Svitek C.A., Oeser J.K., O'Brien R.M. Hepatocyte nuclear factor-4 alpha mediates the stimulatory effect of peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) on glucose-6-phosphatase catalytic subunit gene transcription in H4IIE cells. Biochem. J. 2003, 369:17-22.
16. Braun T.P., Zhu X., Szumowski M., Scott G.D., Grossberg A.J., Levasseur P.R., Graham K., Khan S., Damaraju S., Colmers W.F., Baracos V.E., Marks D.L. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J. Exp. Med. 2011, 208:2449-2463.
17. Brennan-Speranza T.C., Henneicke H., Gasparini S.J., Blankenstein K.I., Heinevetter U., Cogger V.C., Svistounov D., Zhang Y., Cooney G.J., Buttgereit F., Dunstan C.R., Gundberg C., Zhou H., Seibel M.J. Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J. Clin. Invest. 2012, 122:4172-4189.
18. Buren J., Lai Y.C., Lundgren M., Eriksson J.W., Jensen J. Insulin action and signalling in fat and muscle from dexamethasone-treated rats. Arch. Biochem. Biophys. 2008, 474:91-101.
19. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 2004, 4:579-591.
20. Campbell J.E., Peckett A.J., D'Souza A.M., Hawke T.J., Riddell M.C. Adipogenic and lipolytic effects of chronic glucocorticoid exposure. Am. J. Physiol. Cell. Physiol. 2011, 300:C198-C209.
21. Caparroz-Assef S.M., Bersani-Amado C.A., Kelmer-Bracht A.M., Bracht A., Ishii-Iwamoto E.L. The metabolic changes caused by dexamethasone in the adjuvant-induced arthritic rat. Mol. Cell. Biochem. 2007, 302:87-98.
22. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 1995, 332:1351-1362.
23. Coderre L., Srivastava A.K., Chiasson J.L. Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by insulin. Am. J. Physiol. 1992, 262. E427-33.
24. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 1995, 9:1608-1621.
25. Consoli A. Role of liver in pathophysiology of NIDDM. Diabetes Care 1992, 15:430-441.
26. Davani B., Portwood N., Bryzgalova G., Reimer M.K., Heiden T., Ostenson C.G., Okret S., Ahren B., Efendic S., Khan A. Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes. Diabetes 2004, 53(Suppl. 1). S51-9.
27. de Oliveira C., de Mattos A.B., Biz C., Oyama L.M., Ribeiro E.B., do Nascimento C.M. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations. Lipids Health Dis. 2011, 10:11.
28. Delaunay F., Khan A., Cintra A., Davani B., Ling Z.C., Andersson A., Ostenson C.G., Gustafsson J., Efendic S., Okret S. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J. Clin. Invest. 1997, 100:2094-2098.
29. Dimitriadis G., Leighton B., Parry-Billings M., Sasson S., Young M., Krause U., Bevan S., Piva T., Wegener G., Newsholme E.A. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem. J. 1997, 321(Pt 3):707-712.
30. Djurhuus C.B., Gravholt C.H., Nielsen S., Mengel A., Christiansen J.S., Schmitz O.E., Moller N. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am. J. Physiol. Endocrinol. Metab. 2002, 283. E172-7.
31. Dolinsky V.W., Douglas D.N., Lehner R., Vance D.E. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. Biochem. J. 2004, 378:967-974.
32. Drouin J., Trifiro M.A., Plante R.K., Nemer M., Eriksson P., Wrange O. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol. Cell. Biol. 1989, 9:5305-5314.
33. Du K., Herzig S., Kulkarni R.N., Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003, 300:1574-1577.
34. Duma D., Jewell C.M., Cidlowski J.A. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 2006, 102:11-21.
35. Ekstrand A., Schalin-Jantti C., Lofman M., Parkkonen M., Widen E., Franssila-Kallunki A., Saloranta C., Koivisto V., Groop L. The effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantation. Transplantation 1996, 61:889-893.
36. Eloranta J.J., Jung D., Kullak-Ublick G.A. The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. Mol. Endocrinol. 2006, 20:65-79.
37. Feng D., Lazar M.A. Clocks, metabolism, and the epigenome. Mol. Cell 2012, 47:158-167.
38. Fleseriu M., Biller B.M., Findling J.W., Molitch M.E., Schteingart D.E., Gross C. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 2012, 97:2039-2049.
39. Frazier B., Hsiao C.W., Deuster P., Poth M. African Americans and Caucasian Americans: differences in glucocorticoid-induced insulin resistance. Horm. Metab. Res. 2010, 42:887-891.
40. Friedman J.E., Sun Y., Ishizuka T., Farrell C.J., McCormack S.E., Herron L.M., Hakimi P., Lechner P., Yun J.S. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J. Biol. Chem. 1997, 272:31475-31481.
41. Gagner J.P., Drouin J. Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. Mol. Cell. Endocrinol. 1985, 40:25-32.
42. Gagner J.P., Drouin J. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3',5'-cyclic adenosine monophosphate, and glucocorticoids. Mol. Endocrinol. 1987, 1:677-682.
43. Garland R.C. Induction of glucose 6-phosphatase in cultured hepatoma cells by dexamethasone. Biochem. Biophys. Res. Commun. 1986, 139:1130-1134.
44. Garland R.C. Effect of insulin on the induction by dexamethasone of glucose-6-phosphohydrolase and translocase activities in cultured hepatoma cells. Biochem. Biophys. Res. Commun. 1988, 153:307-312.
45. Gesina E., Tronche F., Herrera P., Duchene B., Tales W., Czernichow P., Breant B. Dissecting the role of glucocorticoids on pancreas development. Diabetes 2004, 53:2322-2329.
46. Giordano R., Marzotti S., Berardelli R., Karamouzis I., Brozzetti A., D'Angelo V., Mengozzi G., Mandrile G., Giachino D., Migliaretti G., Bini V., Falorni A., Ghigo E., Arvat E. BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease. Clin. Endocrinol. (Oxf) 2012, 77:863-870.
47. Giorgino F., Almahfouz A., Goodyear L.J., Smith R.J. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J. Clin. Invest. 1993, 91:2020-2030.
48. Glass D.J. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 2005, 37:1974-1984.
49. Gravholt C.H., Dall R., Christiansen J.S., Moller N., Schmitz O. Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans. Obes. Res. 2002, 10:774-781.
50. Gray N.E., Lam L.N., Yang K., Zhou A.Y., Koliwad S., Wang J.C. Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes. J. Biol. Chem. 2012, 287:8444-8456.
51. Gremlich S., Roduit R., Thorens B. Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids. J. Biol. Chem. 1997, 272:3216-3222.
52. Gunn J.M., Hanson R.W., Meyuhas O., Reshef L., Ballard F.J. Glucocorticoids and the regulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in the rat. Biochem. J. 1975, 150:195-203.
53. Hall R.K., Scott D.K., Noisin E.L., Lucas P.C., Granner D.K. Activation of the phosphoenolpyruvate carboxykinase gene retinoic acid response element is dependent on a retinoic acid receptor/coregulator complex. Mol. Cell. Biol. 1992, 12:5527-5535.
54. Hall R.K., Sladek F.M., Granner D.K. The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. Proc. Natl. Acad. Sci. USA 1995, 92:412-416.
55. Hall R.K., Wang X.L., George L., Koch S.R., Granner D.K. Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect. Mol. Endocrinol. 2007, 21:550-563.
56. Hanson R.W., Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 1997, 66:581-611.
57. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell. Biol. 2012, 13:251-262.
58. Hasselgren P.O., Alamdari N., Aversa Z., Gonnella P., Smith I.J., Tizio S. Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:423-428.
59. Hauner H., Schmid P., Pfeiffer E.F. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J. Clin. Endocrinol. Metab. 1987, 64:832-835.
60. Herzig S. Liver: a target of late diabetic complications. Exp. Clin. Endocrinol. Diabetes 2012, 120:202-204.
61. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
62. Heszele M.F., Price S.R. Insulin-like growth factor I: the yin and yang of muscle atrophy. Endocrinology 2004, 145:4803-4805.
63. Horber F.F., Haymond M.W. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J. Clin. Invest. 1990, 86:265-272.
64. Hu Z., Wang H., Lee I.H., Du J., Mitch W.E. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J. Clin. Invest. 2009, 119:3059-3069.
65. Ichijo T., Voutetakis A., Cotrim A.P., Bhattachryya N., Fujii M., Chrousos G.P., Kino T. The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J. Biol. Chem. 2005, 280:42067-42077.
66. Imai E., Stromstedt P.E., Quinn P.G., Carlstedt-Duke J., Gustafsson J.A., Granner D.K. Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 1990, 10:4712-4719.
67. Iynedjian P.B., Hanson R.W. Messenger RNA for renal phosphoenolpyruvate carboxykinase (GTP). Its translation in a heterologous cell-free system and its regulation by glucocorticoids and by changes in acid-base balance. J. Biol. Chem. 1977, 252:8398-8403.
68. Iynedjian P.B., Hanson R.W. Increase in level of functional messenger RNA coding for phosphoenolpyruvate carboxykinase (GTP) during induction by cyclic adenosine 3':5'-monophosphate. J. Biol. Chem. 1977, 252:655-662.
69. Iynedjian P.B., Ballard F.J., Hanson R.W. The regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in rat kidney cortex. The role of acid-base balance and glucocorticoids. J. Biol. Chem. 1975, 250:5596-5603.
70. Jacobson P.B., von Geldern T.W., Ohman L., Osterland M., Wang J., Zinker B., Wilcox D., Nguyen P.T., Mika A., Fung S., Fey T., Goos-Nilsson A., Grynfarb M., Barkhem T., Marsh K., Beno D.W., Nga-Nguyen B., Kym P.R., Link J.T., Tu N., Edgerton D.S., Cherrington A., Efendic S., Lane B.C., Opgenorth T.J. Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes. J. Pharmacol. Exp. Ther. 2005, 314:191-200.
71. Jenson M., Kilroy G., York D.A., Braymer D. Abnormal regulation of hepatic glucocorticoid receptor mRNA and receptor protein distribution in the obese Zucker rat. Obes. Res. 1996, 4:133-143.
72. Jia Y., Viswakarma N., Fu T., Yu S., Rao M.S., Borensztajn J., Reddy J.K. Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis. Gene Exp. 2009, 14:291-306.
73. Jiang Z.Y., Zhou Q.L., Coleman K.A., Chouinard M., Boese Q., Czech M.P. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA 2003, 100:7569-7574.
74. Johnston D.G., Gill A., Orskov H., Batstone G.F., Alberti K.G. Metabolic effects of cortisol in man - studies with somatostatin. Metabolism 1982, 31:312-317.
75. Kellendonk C., Eiden S., Kretz O., Schutz G., Schmidt I., Tronche F., Simon E. Inactivation of the GR in the nervous system affects energy accumulation. Endocrinology 2002, 143:2333-2340.
76. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., Schraw T., Durand J.L., Li H., Li G., Jelicks L.A., Mehler M.F., Hui D.Y., Deshaies Y., Shulman G.I., Schwartz G.J., Scherer P.E. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
77. Kinote A., Faria J.A., Roman E.A., Solon C., Razolli D.S., Ignacio-Souza L.M., Sollon C.S., Nascimento L.F., de Araujo T.M., Barbosa A.P., Lellis-Santos C., Velloso L.A., Bordin S., Anhe G.F. Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels. Endocrinology 2012, 153:3633-3645.
78. Kioussis D., Reshef L., Cohen H., Tilghman S.M., Iynedjian P.B., Ballard F.J., Hanson R.W. Alterations in translatable messenger RNA coding for phosphoenolpyruvate carboxykinase (GTP) in rat liver cytosol during deinduction. J. Biol. Chem. 1978, 253:4327-4332.
79. Koliwad S.K., Kuo T., Shipp L.E., Gray N.E., Backhed F., So A.Y., Farese R.V.Jr., Wang J.C. Angiopoietin-like 4 (ANGPTL4/FIAF) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J. Biol. Chem. 2009.
80. Koo S.H., Satoh H., Herzig S., Lee C.H., Hedrick S., Kulkarni R., Evans R.M., Olefsky J., Montminy M. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 2004, 10:530-534.
81. Krausz Y., Bar-On H., Shafrir E. Origin and pattern of glucocorticoid-induced hyperlipidemia in rats. Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity. Biochim. Biophys. Acta 1981, 663:69-82.
82. Kucera T., Waltner-Law M., Scott D.K., Prasad R., Granner D.K. A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1. J. Biol. Chem. 2002, 277:26098-26102.
83. Kuo T., Lew M.J., Mayba O., Harris C.A., Speed T.P., Wang J.C. Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc. Natl. Acad. Sci. USA 2012, 109:11160-11165.
84. Kusminski C.M., Holland W.L., Sun K., Park J., Spurgin S.B., Lin Y., Askew G.R., Simcox J.A., McClain D.A., Li C., Scherer P.E. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat. Med. 2012, 18:1539-1549.
85. Kusunoki M., Cooney G.J., Hara T., Storlien L.H. Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486. Diabetes 1995, 44:718-720.
86. Lambillotte C., Gilon P., Henquin J.C. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J. Clin. Invest. 1997, 99:414-423.
87. Lamia K.A., Papp S.J., Yu R.T., Barish G.D., Uhlenhaut N.H., Jonker J.W., Downes M., Evans R.M. Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 2011, 480:552-556.
88. Langley S.C., York D.A. Glucocorticoid receptor numbers in the brain and liver of the obese Zucker rat. Int. J. Obes. Relat. Metab. Disord. 1992, 16:135-143.
89. Lemke U., Krones-Herzig A., Diaz M.B., Narvekar P., Ziegler A., Vegiopoulos A., Cato A.C., Bohl S., Klingmuller U., Screaton R.A., Muller-Decker K., Kersten S., Herzig S. The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab. 2008, 8:212-223.
90. Liang Y., Osborne M.C., Monia B.P., Bhanot S., Watts L.M., She P., DeCarlo S.O., Chen X., Demarest K. Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice. Metabolism 2005, 54:848-855.
91. Lin B., Morris D.W., Chou J.Y. Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids. DNA Cell Biol. 1998, 17:967-974.
92. Linssen M.M., van Raalte D.H., Toonen E.J., Alkema W., van der Zon G.C., Dokter W.H., Diamant M., Guigas B., Ouwens D.M. Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells. Cell Signal. 2011, 23:1708-1715.
93. Liu Z., Jahn L.A., Long W., Fryburg D.A., Wei L., Barrett E.J. Branched chain amino acids activate messenger ribonucleic acid translation regulatory proteins in human skeletal muscle, and glucocorticoids blunt this action. J. Clin. Endocrinol. Metab. 2001, 86:2136-2143.
94. Liu Y., Nakagawa Y., Wang Y., Sakurai R., Tripathi P.V., Lutfy K., Friedman T.C. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 2005, 54:32-40.
95. Liu Y., Yan C., Wang Y., Nakagawa Y., Nerio N., Anghel A., Lutfy K., Friedman T.C. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology 2006, 147:5061-5068.
96. Liu Y., Nakagawa Y., Wang Y., Liu L., Du H., Wang W., Ren X., Lutfy K., Friedman T.C. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J. Mol. Endocrinol. 2008, 41:53-64.
97. Liu Y., Su Y., Sun S., Wang T., Qiao X., Run X., Liang Z. Tau phosphorylation and mu-calpain activation mediate the dexamethasone-induced inhibition on the insulin-stimulated Akt phosphorylation. PLoS One 2012, 7:e35783.
98. Long W., Barrett E.J., Wei L., Liu Z. Adrenalectomy enhances the insulin sensitivity of muscle protein synthesis. Am. J. Physiol. Endocrinol. Metab. 2003, 284. E102-9.
99. Loose D.S., Cameron D.K., Short H.P., Hanson R.W. Thyroid hormone regulates transcription of the gene for cytosolic phosphoenolpyruvate carboxykinase (GTP) in rat liver. Biochemistry 1985, 24:4509-4512.
100. Low S.Y., Taylor P.M., Hundal H.S., Pogson C.I., Rennie M.J. Transport of l-glutamine and l-glutamate across sinusoidal membranes of rat liver. Effects of starvation, diabetes and corticosteroid treatment. Biochem. J. 1992, 284(Pt 2):333-340.
101. Lu Y., Zhang Z., Xiong X., Wang X., Li J., Shi G., Yang J., Zhang X., Zhang H., Hong J., Xia X., Ning G., Li X. Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid×receptor. Gastroenterology 2012, 143(1630-1640):e8.
102. Macfarlane D.P., Forbes S., Walker B.R. Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. J. Endocrinol. 2008, 197:189-204.
103. Malkoski S.P., Dorin R.I. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol. Endocrinol. 1999, 13:1629-1644.
104. Marzolla V., Armani A., Zennaro M.C., Cinti F., Mammi C., Fabbri A., Rosano G.M., Caprio M. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol. Cell. Endocrinol. 2012, 350:281-288.
105. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
106. Matthews L.C., Hanley N.A. The stress of starvation: glucocorticoid restraint of beta cell development. Diabetologia 2011, 54:223-226.
107. Mitchell J., Noisin E., Hall R., O'Brien R., Imai E., Granner D. Integration of multiple signals through a complex hormone response unit in the phosphoenolpyruvate carboxykinase gene promoter. Mol. Endocrinol. 1994, 8:585-594.
108. Miyoshi H., Shulman G.I., Peters E.J., Wolfe M.H., Elahi D., Wolfe R.R. Hormonal control of substrate cycling in humans. J. Clin. Invest. 1988, 81:1545-1555.
109. Molusky M.M., Li S., Ma D., Yu L., Lin J.D. Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11beta-hydroxysteroid dehydrogenase 1. Diabetes 2012, 61:1025-1035.
110. Morris S.M., Kepka-Lenhart D. Hormonal induction of hepatic mitochondrial ornithine/citrulline transporter mRNA. Biochem. Biophys. Res. Commun. 2002, 294:749-752.
111. Mueller K.M., Themanns M., Friedbichler K., Kornfeld J.W., Esterbauer H., Tuckermann J.P., Moriggl R. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Mol. Cell. Endocrinol. 2012, 361:1-11.
112. Nader N., Chrousos G.P., Kino T. Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J. 2009, 23:1572-1583.
113. Nader N., Chrousos G.P., Kino T. Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol. Metab. 2010, 21:277-286.
114. Nader N., Ng S.S., Lambrou G.I., Pervanidou P., Wang Y., Chrousos G.P., Kino T. AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol. Endocrinol. 2010, 24:1748-1764.
115. Nader N., Ng S.S., Wang Y., Abel B.S., Chrousos G.P., Kino T. Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism. PLoS One 2012, 7:e26751.
116. Nakae J., Kitamura T., Silver D.L., Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 2001, 108:1359-1367.
117. Newell-Price J., Bertagna X., Grossman A.B., Nieman L.K. Cushing's syndrome. Lancet 2006, 367:1605-1617.
118. Nieman L.K., Chanco Turner M.L. Addison's disease. Clin. Dermatol. 2006, 24:276-280.
119. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 2011, 286:3177-3184.
120. O'Brien R.M., Granner D.K. Regulation of gene expression by insulin. Biochem. J. 1991, 278(Pt 3):609-619.
121. O'Brien R.M., Noisin E.L., Suwanichkul A., Yamasaki T., Lucas P.C., Wang J.C., Powell D.R., Granner D.K. Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol. Cell. Biol. 1995, 15:1747-1758.
122. Oehri M., Ninnis R., Girard J., Frey F.J., Keller U. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans. Am. J. Physiol. 1996, 270. E552-8.
123. Ohshima K., Shargill N.S., Chan T.M., Bray G.A. Adrenalectomy reverses insulin resistance in muscle from obese (ob/ob) mice. Am. J. Physiol. 1984, 246. E193-7.
124. Oishi K., Amagai N., Shirai H., Kadota K., Ohkura N., Ishida N. Genome-wide expression analysis reveals 100 adrenal gland-dependent circadian genes in the mouse liver. DNA Res. 2005, 12:191-202.
125. Opherk C., Tronche F., Kellendonk C., Kohlmuller D., Schulze A., Schmid W., Schutz G. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol. Endocrinol. 2004, 18:1346-1353.
126. Oster H., Damerow S., Kiessling S., Jakubcakova V., Abraham D., Tian J., Hoffmann M.W., Eichele G. The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 2006, 4:163-173.
127. Pantoja C., Huff J.T., Yamamoto K.R. Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol. Biol. Cell 2008, 19:4032-4041.
128. Park M.J., Kong H.J., Kim H.Y., Kim H.H., Kim J.H., Cheong J. Transcriptional repression of gluconeogenic gene PEPCK by orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha. Biochem. J. 2007, 402:567-574.
129. Patel R., Patel M., Tsai R., Lin V., Bookout A.L., Zhang Y., Magomedova L., Li T., Chan J.F., Budd C., Mangelsdorf D.J., Cummins C.L. LXRbeta is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. J. Clin. Invest. 2011, 121:431-441.
130. Peckett A.J., Wright D.C., Riddell M.C. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 2011, 60:1500-1510.
131. Pessin J.E., Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 2000, 106:165-169.
132. Phillips D.I., Barker D.J., Fall C.H., Seckl J.R., Whorwood C.B., Wood P.J., Walker B.R. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?. J. Clin. Endocrinol. Metab. 1998, 83:757-760.
133. Phuc Le P., Friedman J.R., Schug J., Brestelli J.E., Parker J.B., Bochkis I.M., Kaestner K.H. Glucocorticoid receptor-dependent gene regulatory networks. PLoS Genet. 2005, 1:e16.
134. Pierreux C.E., Urso B., De Meyts P., Rousseau G.G., Lemaigre F.P. Inhibition by insulin of glucocorticoid-induced gene transcription: involvement of the ligand-binding domain of the glucocorticoid receptor and independence from the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Mol. Endocrinol. 1998, 12:1343-1354.
135. Pijl H., Meinders A.E. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf. 1996, 14:329-342.
136. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003, 24:78-90.
137. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
138. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
139. Raber J. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits. Mol. Neurobiol. 1998, 18:1-22.
140. Ralliere C., Tauveron I., Taillandier D., Guy L., Boiteux J.P., Giraud B., Attaix D., Thieblot P. Glucocorticoids do not regulate the expression of proteolytic genes in skeletal muscle from Cushing's syndrome patients. J. Clin. Endocrinol. Metab. 1997, 82:3161-3164.
141. Ranta F., Avram D., Berchtold S., Dufer M., Drews G., Lang F., Ullrich S. Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes 2006, 55:1380-1390.
142. Rebuffe-Scrive M., Krotkiewski M., Elfverson J., Bjorntorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J. Clin. Endocrinol. Metab. 1988, 67:1122-1128.
143. Reich E., Tamary A., Sionov R.V., Melloul D. Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death. Diabetologia 2012, 55:1048-1057.
144. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., Schutz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998, 93:531-541.
145. Reichardt S.D., Foller M., Rexhepaj R., Pathare G., Minnich K., Tuckermann J.P., Lang F., Reichardt H.M. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes. Endocrinology 2012, 153:1783-1794.
146. Ren R., Oakley R.H., Cruz-Topete D., Cidlowski J.A. Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology 2012, 153:5346-5360.
147. Renga B., Mencarelli A., D'Amore C., Cipriani S., Baldelli F., Zampella A., Distrutti E., Fiorucci S. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. FASEB J. 2012, 26:3021-3031.
148. Reynolds R.M., Walker B.R., Syddall H.E., Andrew R., Wood P.J., Whorwood C.B., Phillips D.I. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 2001, 86:245-250.
149. Reynolds R.M., Walker B.R., Syddall H.E., Whorwood C.B., Wood P.J., Phillips D.I. Elevated plasma cortisol in glucose-intolerant men: differences in responses to glucose and habituation to venepuncture. J. Clin. Endocrinol. Metab. 2001, 86:1149-1153.
150. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzalez F.J., Spiegelman B.M. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:4012-4017.
151. Rose A.J., Vegiopoulos A., Herzig S. Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J. Steroid Biochem. Mol. Biol. 2010, 122:10-20.
152. Rose A.J., Diaz M.B., Reimann A., Klement J., Walcher T., Krones-Herzig A., Strobel O., Werner J., Peters A., Kleyman A., Tuckermann J.P., Vegiopoulos A., Herzig S. Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metab. 2011, 14:123-130.
153. Ryan W.L., Carver M.J. Immediated and prolonged effects of hydrocortisone on the free amino acids of rat skeletal muscle. Proc. Soc. Exp. Biol. Med. 1963, 114:816-819.
154. Saad M.J., Folli F., Kahn J.A., Kahn C.R. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest. 1993, 92:2065-2072.
155. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001, 104:517-529.
156. Samra J.S., Clark M.L., Humphreys S.M., MacDonald I.A., Bannister P.A., Frayn K.N. Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J. Clin. Endocrinol. Metab. 1998, 83:626-631.
157. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
158. Saunders J., Hall S.E., Sonksen P.H. Glucose and free fatty acid turnover in Cushing's syndrome. J. Endocrinol. Invest. 1980, 3:309-311.
159. Schacke H., Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 2002, 96:23-43.
160. Schmid J., Ludwig B., Schally A.V., Steffen A., Ziegler C.G., Block N.L., Koutmani Y., Brendel M.D., Karalis K.P., Simeonovic C.J., Licinio J., Ehrhart-Bornstein M., Bornstein S.R. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase. Proc. Natl. Acad. Sci. USA 2011, 108:13722-13727.
161. Schmoll D., Allan B.B., Burchell A. Cloning and sequencing of the 5' region of the human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells. FEBS Lett. 1996, 383:63-66.
162. Schmoll D., Wasner C., Hinds C.J., Allan B.B., Walther R., Burchell A. Identification of a cAMP response element within the glucose-6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells. Biochem. J. 1999, 338(Pt 2):457-463.
163. Scott D.K., Mitchell J.A., Granner D.K. The orphan receptor COUP-TF binds to a third glucocorticoid accessory factor element within the phosphoenolpyruvate carboxykinase gene promoter. J. Biol. Chem. 1996, 271:31909-31914.
164. Shibli-Rahhal A., Van Beek M., Schlechte J.A. Cushing's syndrome. Clin. Dermatol. 2006, 24:260-265.
165. Shimizu N., Yoshikawa N., Ito N., Maruyama T., Suzuki Y., Takeda S., Nakae J., Tagata Y., Nishitani S., Takehana K., Sano M., Fukuda K., Suematsu M., Morimoto C., Tanaka H. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab. 2011, 13:170-182.
166. Short K.R., Nygren J., Bigelow M.L., Nair K.S. Effect of short-term prednisone use on blood flow, muscle protein metabolism, and function. J. Clin. Endocrinol. Metab. 2004, 89:6198-6207.
167. Short K.R., Bigelow M.L., Nair K.S. Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy people. Am. J. Physiol. Endocrinol. Metab. 2009, 297. E1260-8.
168. Shteyer E., Liao Y., Muglia L.J., Hruz P.W., Rudnick D.A. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 2004, 40:1322-1332.
169. Silverman M.N., Mukhopadhyay P., Belyavskaya E., Tonelli L.H., Revenis B.D., Doran J.H., Ballard B.E., Tam J., Pacher P., Sternberg E.M. Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Mol. Psychiatry 2012.
170. So A.Y., Bernal T.U., Pillsbury M.L., Yamamoto K.R., Feldman B.J. Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc. Natl. Acad. Sci. USA 2009, 106:17582-17587.
171. Solomon J., Mayer J. The effect of adrenalectomy on the development of the obese-hyperglycemic syndrome in ob-ob mice. Endocrinology 1973, 93:510-512.
172. Sommerfeld A., Krones-Herzig A., Herzig S. Transcriptional co-factors and hepatic energy metabolism. Mol. Cell. Endocrinol. 2011, 332:21-31.
173. Stafford J.M., Wilkinson J.C., Beechem J.M., Granner D.K. Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter. J. Biol. Chem. 2001, 276:39885-39891.
174. Stafford J.M., Waltner-Law M., Granner D.K. Role of accessory factors and steroid receptor coactivator 1 in the regulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. J. Biol. Chem. 2001, 276:3811-3819.
175. Tata J.R. Signalling through nuclear receptors. Nat. Rev. Mol. Cell. Biol. 2002, 3:702-710.
176. Tilghman S.M., Hanson R.W., Reshef L., Hopgood M.F., Ballard F.J. Rapid loss of translatable messenger RNA of phosphoenolpyruvate carboxykinase during glucose repression in liver. Proc. Natl. Acad. Sci. USA 1974, 71:1304-1308.
177. Tilghman S.M., Gunn J.M., Fisher L.M., Hanson R.W. Deinduction of phosphoenolpyruvate carboxykinase (guanosine triphosphate) synthesis in Reuber H-35 cells. J. Biol. Chem. 1975, 250:3322-3329.
178. Tontonoz P., Hu E., Devine J., Beale E.G., Spiegelman B.M. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 1995, 15:351-357.
179. Trementino L., Appolloni G., Concettoni C., Cardinaletti M., Boscaro M., Arnaldi G. Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome. Eur. J. Endocrinol. 2012, 166:35-42.
180. Tronche F., Opherk C., Moriggl R., Kellendonk C., Reimann A., Schwake L., Reichardt H.M., Stangl K., Gau D., Hoeflich A., Beug H., Schmid W., Schutz G. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev. 2004, 18:492-497.
181. Tsai H.J., Romsos D.R. Glucocorticoid and mineralocorticoid receptor-binding characteristics in obese (ob/ob) mice. Am. J. Physiol. 1991, 261. E495-9.
182. Ulbright C., Snodgrass P.J. Coordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanisms. Arch. Biochem. Biophys. 1993, 301:237-243.
183. Ullrich S., Berchtold S., Ranta F., Seebohm G., Henke G., Lupescu A., Mack A.F., Chao C.M., Su J., Nitschke R., Alexander D., Friedrich B., Wulff P., Kuhl D., Lang F. Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion. Diabetes 2005, 54:1090-1099.
184. Valtat B., Dupuis C., Zenaty D., Singh-Estivalet A., Tronche F., Breant B., Blondeau B. Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice. Diabetologia 2011, 54:350-359.
185. van den Berghe G. The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. J. Inherit. Metab. Dis. 1991, 14:407-420.
186. van Raalte D.H., Brands M., van der Zijl N.J., Muskiet M.H., Pouwels P.J., Ackermans M.T., Sauerwein H.P., Serlie M.J., Diamant M. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia 2011, 54:2103-2112.
187. van Raalte D.H., Brands M., Serlie M.J., Mudde K., Stienstra R., Sauerwein H.P., Kersten S., Diamant M. Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans. Exp. Clin. Endocrinol. Diabetes 2012, 120:598-603.
188. Vander Kooi B.T., Onuma H., Oeser J.K., Svitek C.A., Allen S.R., Vander Kooi C.W., Chazin W.J., O'Brien R.M. The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements. Mol. Endocrinol. 2005, 19:3001-3022.
189. Vegiopoulos A., Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol. Cell. Endocrinol. 2007, 275:43-61.
190. Vestergaard H., Bratholm P., Christensen N.J. Increments in insulin sensitivity during intensive treatment are closely correlated with decrements in glucocorticoid receptor mRNA in skeletal muscle from patients with Type II diabetes. Clin. Sci. (Lond.) 2001, 101:533-540.
191. Viguerie N., Picard F., Hul G., Roussel B., Barbe P., Iacovoni J.S., Valle C., Langin D., Saris W.H. Multiple effects of a short-term dexamethasone treatment in human skeletal muscle and adipose tissue. Physiol. Genomics 2012, 44:141-151.
192. von Geldern T.W., Tu N., Kym P.R., Link J.T., Jae H.S., Lai C., Apelqvist T., Rhonnstad P., Hagberg L., Koehler K., Grynfarb M., Goos-Nilsson A., Sandberg J., Osterlund M., Barkhem T., Hoglund M., Wang J., Fung S., Wilcox D., Nguyen P., Jakob C., Hutchins C., Farnegardh M., Kauppi B., Ohman L., Jacobson P.B. Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes. J. Med. Chem. 2004, 47:4213-4230.
193. Wang J.C., Stromstedt P.E., O'Brien R.M., Granner D.K. Hepatic nuclear factor 3 is an accessory factor required for the stimulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. Mol. Endocrinol. 1996, 10:794-800.
194. Wang X.L., Herzog B., Waltner-Law M., Hall R.K., Shiota M., Granner D.K. The synergistic effect of dexamethasone and all-trans-retinoic acid on hepatic phosphoenolpyruvate carboxykinase gene expression involves the coactivator p300. J. Biol. Chem. 2004, 279:34191-34200.
195. Wang J.C., Gray N.E., Kuo T., Harris C.A. Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci. 2012, 2:19.
196. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., Messaddeq N., Harney J.W., Ezaki O., Kodama T., Schoonjans K., Bianco A.C., Auwerx J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
197. Watson M.L., Baehr L.M., Reichardt H.M., Tuckermann J.P., Bodine S.C., Furlow J.D. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. Am. J. Physiol. Endocrinol. Metab. 2012, 302. E1210-20.
198. Watts L.M., Manchem V.P., Leedom T.A., Rivard A.L., McKay R.A., Bao D., Neroladakis T., Monia B.P., Bodenmiller D.M., Cao J.X., Zhang H.Y., Cox A.L., Jacobs S.J., Michael M.D., Sloop K.W., Bhanot S. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism. Diabetes 2005, 54:1846-1853.
199. Weinstein S.P., Paquin T., Pritsker A., Haber R.S. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes 1995, 44:441-445.
200. Weinstein S.P., Wilson C.M., Pritsker A., Cushman S.W. Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism 1998, 47:3-6.
201. Whorwood C.B., Donovan S.J., Flanagan D., Phillips D.I., Byrne C.D. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 2002, 51:1066-1075.
202. Winkler R., Benz V., Clemenz M., Bloch M., Foryst-Ludwig A., Wardat S., Witte N., Trappiel M., Namsolleck P., Mai K., Spranger J., Matthias G., Roloff T., Truee O., Kappert K., Schupp M., Matthias P., Kintscher U. Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis. Diabetes 2012, 61:513-523.
203. Wise J.K., Hendler R., Felig P. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J. Clin. Invest. 1973, 52:2774-2782.
204. Wolfrum C., Asilmaz E., Luca E., Friedman J.M., Stoffel M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 2004, 432:1027-1032.
205. Yamada K., Duong D.T., Scott D.K., Wang J.C., Granner D.K. CCAAT/enhancer-binding protein beta is an accessory factor for the glucocorticoid response from the cAMP response element in the rat phosphoenolpyruvate carboxykinase gene promoter. J. Biol. Chem. 1999, 274:5880-5887.
206. Yang S., Liu A., Weidenhammer A., Cooksey R.C., McClain D., Kim M.K., Aguilera G., Abel E.D., Chung J.H. The role of mPer2 clock gene in glucocorticoid and feeding rhythms. Endocrinology 2009, 150:2153-2160.
207. Yi C.X., Foppen E., Abplanalp W., Gao Y., Alkemade A., la Fleur S.E., Serlie M.J., Fliers E., Buijs R.M., Tschop M.H., Kalsbeek A. Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity. Diabetes 2012, 61:339-345.
208. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
209. You Y.N., Short K.R., Jourdan M., Klaus K.A., Walrand S., Nair K.S. The effect of high glucocorticoid administration and food restriction on rodent skeletal muscle mitochondrial function and protein metabolism. PLoS One 2009, 4:e5283.
210. Yu C.Y., Mayba O., Lee J.V., Tran J., Harris C., Speed T.P., Wang J.C. Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One 2010, 5:e15188.
211. Zennaro M.C., Caprio M., Feve B. Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol. Metab. 2009, 20:444-451.